Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations

Patrick John Finn, President and COO of Twist Bioscience, sold 2,845 shares of common stock on February 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Patrick John Finn, the President and COO of Twist Bioscience, sold 2,845 shares of the company's common stock on February 3, 2025.
• The sale was executed at a price of $49.352 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Finn directly owns 269,199 shares of Twist Bioscience.
• The sale was mandated by Twist Bioscience's equity incentive plan, which requires a 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale to cover tax obligations, which is a common practice. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Insider sales, especially those related to covering tax obligations, are common and generally don't indicate a negative outlook for the company. However, large or frequent insider sales can sometimes raise concerns among investors.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact as it is for tax obligations.

Key Dates